Abstract
The objective of this study was to investigate the association between the heparan sulfate proteoglycan (HSPG) gene G/T polymorphism and diabetic nephropathy in type 2 diabetes in Chinese. The HSPG gene polymorphism (G/T) was determined using polymerase chain reaction – restriction fragment length polymorphism (PCR-RFLP) in 290 Chinese type 2 diabetes mellitus patients comprising 77 cases without nephropathy and 213 cases with nephropathy with either proteinuria (163) or renal insufficiency (50) and a control group of 190 non-diabetics. A significant increase in the frequencies of the T allele and TT + TG genotype was observed in subjects with diabetic renal insufficiency as compared with diabetic subjects without nephropathy and those with diabetic proteinuria (for the T allele: Fisher's two-tailed exact p was 0.015 and 0.002, respectively; for the TT + TG genotype; both p values were < 0.001). Diabetic subjects without nephropathy and those with albuminuria carrying the T allele had odds ratios for the development of renal insufficiency of 1.92 (95% CI, 1.12–3.30) and 2.09 (95% CI, 1.29–3.38), respectively, as compared to non-carriers. The T allele of the HSPG gene BamHI polymorphism located in intron 6 may be a risk factor for the development of renal insufficiency in type 2 diabetes mellitus for Chinese.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Raskin P: Risk factors for the development of diabetic complications. J Diabetes Complications 8: 195-200, 1994
Diabetic Chronic Complications Trial (DCCT) Research Group: Clustering of long-term complications in families with diabetes in the DCCT. Diabetes 46: 1889-1892, 1997
Van den Born J, van den Heuvel LPWJ, Bakker MAH, Veerkamp JH, Berden JHM: A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 41: 115-123, 1992
Tamsma J-T, van den Born J, Bruijn JA, Assmann KJM, Weening JJ: Expression of glomerular extracellular matrix components in human diabetic nephropathy: Decrease of heparan sulfate in the glomerular basement membrane. Diabetologia 37: 313-320, 1994
Hansen PM, Chowdhury T, Deckert T, Hellgren A, Bain SC, Pociot F: Genetic variation of the heparan sulfate proteoglycan gene (perlecan gene), association with urinary albumin excretion in IDDM patients. Diabetes 46: 1658-1659, 1997
Hiroki F, Takuma N, Hiroyuki M: Lack of association between the heparan sulfate proteoglycan gene polymorphism and diabetic nephropathy in Japanese NIDDM with proliferative diabetic retinopathy. Renal Failure 21: 659, 1999
Warram JH, Gearin G, Laffel L, Krolewski AS: Effect of duration of type 1 diabetes on prevalence of stages of nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 7: 930-937, 1996
The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
Krolewski AS, Laffel LM, Krolewski M, Quinn M, Warram JH: Glycated hemoglobin and risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332: 1251-1255, 1995
Parving HH, Andersen AR, Smidt UM, Hommel E, Svendsen PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294: 1443-1447, 1987
Chowdhury TA, Dyer PH, Kumar S, Barnett AH, Bain SC: Genetic determinants of diabetic nephropathy. Clin Sci 96: 221-230, 1999
Borch-Johnsen K, Norgaard K, Hommel E, Methiesen ER, Jensen JS, Deckert T, Parving HH: Is diabetic nephropathy an inherited complication? Kidney Int 41: 719-722, 1992
Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC: Familial prodisposition to renal disease in two generations of Pima Indians with type2 (non-insulin-dependent diabetes mellitus). Diabetologia 33: 438-443, 1990
Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ: The excess incidence of diabetic end-stage renal disease among blacks. JAMA 268: 3079-3084, 1992
Freedman BI, Tuffle AB, Spray BJ: Familial predisposition to nephropathy in African American with non-insulin-dependent diabetes mellitus. Am J kidney Dis 25: 710-713, 1995
Krolewski AS: Genetics of diabetic nephropathy: Evidence for major and minor gene effects. Kidney Int 55: 1582-1596, 1999
Heesom AE, Hibberd ML, Millward A, Demaine AG: Polymorphism in the 5′-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type1 diabetes. Diabetes 46: 287-291, 1997
Eto M, Horita K, Morikawa A, Nakata H, Okada M, Saito M, Nomura M, Abiko A, Iwashima Y, Ikoda A: Increased frequency of apolipoprotein ε2 allele in non-insulin dependent diabetic patients with nephropathy. Clin Genet 48: 288-292, 1995
Mizuiri S, Hemmi H, Inoue A, Yoshikawa H, Tanegashima M, Fushimi T, Ishigami M, Amagasaki Y, Ohara T, Shimatake H: Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 70: 455-459, 1995
Kallunki P, Tryggvason K: Human basement membrane heparan sulfate proteoglycan core protein: A 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J Cell Biol 116: 559-571, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liu, L., Xiang, K., Zheng, T. et al. The heparan sulfate proteoglycan gene polymorphism: Association with type 2 diabetic nephropathy in Chinese. Mol Cell Biochem 245, 121–126 (2003). https://doi.org/10.1023/A:1022870128494
Issue Date:
DOI: https://doi.org/10.1023/A:1022870128494